Suppr超能文献

COVID-19 感染住院患者中炎症标志物的性别差异:来自 MGH COVID-19 患者登记处的见解。

Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry.

机构信息

From the Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, United States of America.

Division of Cardiology, Massachusetts General Hospital, Boston, MA, United States of America.

出版信息

PLoS One. 2021 Apr 28;16(4):e0250774. doi: 10.1371/journal.pone.0250774. eCollection 2021.

Abstract

BACKGROUND

Men are at higher risk for serious complications related to COVID-19 infection than women. More robust immune activation in women has been proposed to contribute to decreased disease severity, although systemic inflammation has been associated with worse outcomes in COVID-19 infection. Whether systemic inflammation contributes to sex differences in COVID-19 infection is not known.

STUDY DESIGN AND METHODS

We examined sex differences in inflammatory markers among 453 men (mean age 61) and 328 women (mean age 62) hospitalized with COVID-19 infection at the Massachusetts General Hospital from March 8 to April 27, 2020. Multivariable linear regression models were used to examine the association of sex with initial and peak inflammatory markers. Exploratory analyses examined the association of sex and inflammatory markers with 28-day clinical outcomes using multivariable logistic regression.

RESULTS

Initial and peak CRP were higher in men compared with women after adjustment for baseline differences (initial CRP: ß 0.29, SE 0.07, p = 0.0001; peak CRP: ß 0.31, SE 0.07, p<0.0001) with similar findings for IL-6, PCT, and ferritin (p<0.05 for all). Men had greater than 1.5-greater odds of dying compared with women (OR 1.71, 95% CI 1.04-2.80, p = 0.03). Sex modified the association of peak CRP with both death and ICU admission, with stronger associations observed in men compared with women (death: OR 9.19, 95% CI 4.29-19.7, p <0.0001 in men vs OR 2.81, 95% CI 1.52-5.18, p = 0.009 in women, Pinteraction = 0.02).

CONCLUSIONS

In a sample of 781 men and women hospitalized with COVID-19 infection, men exhibited more robust inflammatory activation as evidenced by higher initial and peak inflammatory markers, as well as worse clinical outcomes. Better understanding of sex differences in immune responses to COVID-19 infection may shed light on the pathophysiology of COVID-19 infection.

摘要

背景

男性因 COVID-19 感染而出现严重并发症的风险高于女性。有研究提出,女性的免疫激活更为强烈,这有助于降低疾病的严重程度,尽管全身性炎症与 COVID-19 感染的不良结局有关。但目前尚不清楚全身性炎症是否导致 COVID-19 感染中存在性别差异。

研究设计与方法

我们对 2020 年 3 月 8 日至 4 月 27 日期间在马萨诸塞州综合医院因 COVID-19 感染住院的 453 名男性(平均年龄 61 岁)和 328 名女性(平均年龄 62 岁)的炎症标志物进行了性别差异分析。采用多变量线性回归模型来检验性别与初始和峰值炎症标志物之间的关联。采用多变量逻辑回归分析对炎症标志物与 28 天临床结局之间的关系进行了探索性分析。

结果

在调整基线差异后,与女性相比,男性的初始和峰值 CRP 更高(初始 CRP:β0.29,SE0.07,p=0.0001;峰值 CRP:β0.31,SE0.07,p<0.0001),IL-6、PCT 和铁蛋白也存在类似的差异(p<0.05)。与女性相比,男性死亡的可能性是女性的 1.71 倍(OR1.71,95%CI1.04-2.80,p=0.03)。性别改变了峰值 CRP 与死亡和 ICU 入院之间的关联,与女性相比,这种关联在男性中更为明显(死亡:OR9.19,95%CI4.29-19.7,p<0.0001 与 OR2.81,95%CI1.52-5.18,p=0.009,P 交互=0.02)。

结论

在一项 781 名男性和女性 COVID-19 感染住院患者的样本中,男性表现出更强的炎症激活,表现为更高的初始和峰值炎症标志物,以及更差的临床结局。更好地了解 COVID-19 感染中免疫反应的性别差异可能有助于阐明 COVID-19 感染的病理生理学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da1a/8081177/b3cb9d554b5f/pone.0250774.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验